Methods for altering cell fate
View Patent ↗The invention provides methods for altering the expression profile of a cell to convert the cell from one cell type to a desired cell type. These reprogrammed cells may be used in a variety of medical applications for treating a mammal in need of a particular cell type.
1. A method of altering gene expression of a mammalian fibroblast, said method comprising incubating a permeabilized fibroblast with an activated T-cell extract, said permeabilized fibroblast having pores in its plasma membrane or a partial plasma membrane, wherein said incubation results in an alteration of gene expression in said fibroblast, wherein said fibroblast with altered gene expression expresses IL-2 receptor.
2. The method of claim 1 , wherein the fibroblast with altered gene expression is incubated under conditions that allow the membrane of said fibroblast to reseal.
3. The method of claim 1 , wherein said fibroblast is permeabilized by incubating an intact fibroblast with a detergent or a bacterial toxin.
4. The method of claim 3 , wherein said bacterial toxin is Streptolysin O.
5. The method of claim 1 , wherein said fibroblast or said T-cell is a human cell.
6. The method of claim 1 , wherein said permeabilized fibroblast is an interphase or mitotic cell.
7. The method of claim 1 , wherein said alteration in gene expression involves a DNA methyltransferase, histone deacetylase, histone, nuclear lamin, activator, repressor, growth factor, hormone, or cytokine.
8. A method of altering gene expression of a mammalian fibroblast, said method comprising incubating a permeabilized mammalian fibroblast with an interphase cell extract from an embryonic stem cell, said permeabilized mammalian fibroblast having pores in its plasma membrane or a partial plasma membrane, wherein said incubation results in an alteration of gene expression in said mammalian fibroblast, wherein said fibroblast with altered gene expression expresses Oct4 or alkaline phosphatase.
9. The method of claim 8 , wherein said mammalian fibroblast or said embryonic stem cell is a human cell.
10. The method of claim 8 , wherein said fibroblast with altered gene expression forms embryonic stem cell-like colonies.
11. The method of claim 8 , wherein said fibroblast with altered gene expression forms embryoid bodies.
12. The method of claim 8 , wherein the fibroblast with altered gene expression is incubated under conditions that allow the membrane of said fibroblast to reseal.
13. The method of claim 8 , wherein said mammalian fibroblast is permeabilized by incubating an intact cell with a detergent or a bacterial toxin.
14. The method of claim 13 , wherein said bacterial toxin is Streptolysin O.
15. A method of altering gene expression of a mammalian fibroblast, said method comprising incubating a permeabilized mammalian fibroblast with an interphase cell extract from a neural cell, said permeabilized mammalian fibroblast having pores in its plasma membrane or a partial plasma membrane, wherein said incubation results in an alteration of gene expression in said mammalian fibroblast, wherein said fibroblast with altered gene expression expresses neurofilament protein NF200.
16. The method of claim 15 , wherein said neural cell is a neuronal precursor cell.
17. The method of claim 15 , wherein said mammalian fibroblast or said neural cell is a human cell.
18. The method of claim 15 , wherein said fibroblast with altered gene expression forms a neurofilament, neurite, or axon.
19. The method of claim 15 , wherein said fibroblast with altered gene expression divides or is immortalized.
20. The method of claim 15 , wherein the fibroblast with altered gene expression is incubated under conditions that allow the membrane of said fibroblast to reseal.
21. The method of claim 15 , wherein said mammalian fibroblast is permeabilized by incubating an intact cell with a detergent or a bacterial toxin.
22. The method of claim 15 , wherein said bacterial toxin is Streptolysin O.